Red blood cell immunization in sickle cell disease: Evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype

Haematologica

Volumn 99, Issue 7, 2014, Pages

  Silvy, Monique ^a,b   Tournamille, Christophe ^a,c   Babinet, Jérôme ^a   Pakdaman, Sadaf ^a,c   Cohen, Sylvain ^a   Chiaroni, Jacques ^a,b   Galactéros, Frédéric ^c,d   Bierling, Philippe ^a,c   Bailly, Pascal ^a,b   Noizat Pirenne, France ^a,c  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c INSERM   (France)

^d HENRI MONDOR HOSPITAL   (France)

Author keywords

Frequencies of RH allele variants; Sickle cell disease; Transfusion strategy

Indexed keywords

ERYTHROCYTE ANTIGEN; RHESUS ANTIBODY; RHESUS D ANTIGEN; ALLOANTIBODY; ANTIBODY; BLOOD GROUP RHESUS SYSTEM;

ALLELE; ALLOIMMUNIZATION; BLOOD GROUP ABO SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD GROUP RH; BLOOD TRANSFUSION; ERYTHROCYTE; HETEROZYGOSITY; HUMAN; IMMUNE RESPONSE; LETTER; MAJOR CLINICAL STUDY; PHENOTYPE; RHESUS IMMUNIZATION; RISK FACTOR; SICKLE CELL ANEMIA; BLOOD; BLOOD GROUP RHESUS SYSTEM; IMMUNIZATION; IMMUNOLOGY;

ANEMIA, SICKLE CELL; ANTIBODIES; ERYTHROCYTES; HUMANS; IMMUNIZATION; ISOANTIBODIES; PHENOTYPE; RH-HR BLOOD-GROUP SYSTEM;

EID: 84901601109     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2014.104703     Document Type: Letter

References (11)

1. Higgins JM, Sloan SR. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood. 2008;112(6):2546-53.
2. Bashmri LA. Red cell alloimmunization in sickle-cell anaemia patients. East Mediterr Health J. 2007;13(5):1181-9.
3. Winkler AM, Josephson CD. Transfusion practices for patients with sickle cell disease at major academic medical centers participating in the Atlanta Sickle Cell Consortium. Immunohematology. 2012;28(1):24-6.
4. Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM. The sickle cell hemolytic transfusion reaction syndrome. Transfusion. 1997;37(4):382-92.
5. Scheunemann LP, Ataga KI. Delayed hemolytic transfusion reaction in sickle cell disease. Am J Med Sci. 2010;339(3):266-9.
6. Yazdanbakhsh K, Ware RE, Noizat-Pirenne F. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood. 2012;120(3):528-37.
7. Liu C, Grossman BJ. Antibody of undetermined specificity: frequency, laboratory features, and natural history. Transfusion. 2013;53(5):931-8.
8. Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood. 2013;122(6):1062-71.
9. Noizat-Pirenne F, Lee K, Pennec PY, Simon P, Kazup P, Bachir D, et al. Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood. 2002;100(12): 4223-31.
10. Silvy M, Di Cristofaro J, Beley S, Papa K, Rits M, Chiaroni J, et al. Identification of RHCE and KEL alleles in large cohorts of Afro-Caribbean and Comorian donors by multiplex SNaPshot and fragment assays: a transfusion support for sickle cell disease patients. Br J Haematol. 2011;154(2):260-70.
11. Badjie KS, Tauscher CD, van Buskirk CM, Wong C, Jenkins SM, Smith CY, et al. Red blood cell phenotype matching for various ethnic groups. Immunohematology. 2011;27(1):12-9.